| Bioactivity | HOXB7 8–25 (MDM2 32-46) is an MDM2-derived peptide epitope and can elicit antigen-specifc and tumor-reactive CD4+ T cell responses[1]. |
| Name | HOXB7 8–25 |
| Sequence | Pro-Leu-Leu-Leu-Lys-Leu-Leu-Lys-Ser-Val-Gly-Ala-Gln-Lys-Asp |
| Shortening | PLLLKLLKSVGAQKD |
| Formula | C75H135N19O20 |
| Molar Mass | 1622.99 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Kono M, et al. Interruption of MDM2 signaling augments MDM2-targeted T cell-based antitumor immunotherapy through antigen-presenting machinery. Cancer Immunol Immunother. 2021;70(12):3421-3434. |